humana inc (HUM) Key Developments
Humana Inc. Presents at The Economist Health Care Forum, Sep-17-2014 08:45 AM
Sep 4 14
Humana Inc. Presents at The Economist Health Care Forum, Sep-17-2014 08:45 AM. Venue: Seaport Boston Hotel, 1 Seaport Lane, Boston, MA 02210, United States. Speakers: Bruce D. Broussard, Chief Executive Officer, President, Director and Chairman of Executive Committee.
Humana Declares Quarterly Cash Dividend, Payable on October 31, 2014
Aug 27 14
Humana Inc. announced that its Board of Directors has declared a cash dividend to stockholders of $0.28 per share payable on October 31, 2014 to stockholders of record as of the close of business on September 30, 2014.
Humana Inc. and Nebraska Health Network Announce Partnership for 2015
Aug 26 14
Humana Inc. and Nebraska Health Network announced the partnership will begin January 1, 2015. The partnership is based on a pay-for-value system focused on promoting evidence-based, highly-integrated care, which can lead to improved medical outcomes, a better patient experience and lower costs. The new 2015 agreement will offer a more robust level of care coordination and quality improvements. Humana and the Nebraska Health Network are working together to enhance medical records infrastructure and further collaboration on disease management and prevention, like diabetes care and treatment, breast cancer screenings, colorectal cancer screenings and high-risk medication.
Humana Inc. Announces Earnings Results for the Second Quarter and Six Months Ended June 30, 2014; Reaffirms Earnings Guidance for the Year Ending December 31, 2014
Jul 30 14
Humana Inc. announced earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported diluted earnings per common share (EPS) of $2.19, compared to diluted earnings per common share (EPS) of $2.63 for the quarter ended June 30, 2013. As expected, EPS for second quarter of 2014 was lower than that for second quarter of 2013 due primarily to investments in health care exchanges and state-based contracts and higher specialty drug costs associated with a new treatment of Hepatitis C, partially offset by membership growth and a lower diluted share count. The company said net income fell to $344 million from $420 million in the same quarter a year ago. Revenue rose 18% to $12.22 billion from $10.32 billion in the same quarter a year earlier. A year-over-year increase in premiums and services revenue was driven by higher medical membership in the Retail segment and higher group Medicare Advantage membership in the Employer Group segment.
For the six months ended June 30, 2014, the company reported EPS of $4.54 compared to $5.58 in the six months ended June 30, 2013. The lower year-over-year earnings year to date reflected the items discussed above as well as $0.41 per share benefit in first half of 2013 from the settlement of contract claims with the Department of Defense (DoD) related to previously-disclosed litigation and the absence of the impact of sequestration for the company's Medicare business.
The company reaffirmed its estimate for EPS for the year ending December 31, 2014 to be in the range of $7.25 to $7.75.
Humana Appoints Douglas M. Stoss as Vice President of Federal Affairs
Jul 7 14
Humana announced that it has appointed Douglas M. Stoss as vice president of federal affairs.